Publication:
Minimising metabolic and cardiovascular risk in schizophrenia: diabetes, obesity and dyslipidaemia (2007)
Author(s): Barnett AH, Mackin P, Chaudhury I, Farooqi A, Gadsby R, Heald A, Hill J, Millar H, Peveler R, Rees A, Singh V, Taylor D, Vora J, Jones PB
- Date: 01-06-2007
- Journal: Journal of Psychopharmacology
- Volume: 21
- Issue: 4
- Pages: 357-373
- Publisher: Sage Publications Ltd.
- Publication type: Article
- Bibliographic status: Published
- URL: http://dx.doi.org/10.1177/0269881107075509
- DOI: 10.1177/0269881107075509
- ISSN (electronic): 1461-7285
Keywords: antipsychotic cardiovascular disease diabetes dyslipidaemia hypertension metabolic syndrome obesity schizophrenia INDUCED WEIGHT-GAIN BODY-MASS INDEX IMPAIRED FASTING GLUCOSE HEALTH PLAN DATABASE ANTIPSYCHOTIC-DRUGS ATYPICAL ANTIPSYCHOTICS INSULIN-RESISTANCE WAIST CIRCUMFERENCE CONTROLLED-TRIAL SHORT-TERM
